Production and Characterization of Hirudin Variant-1 by SUMO Fusion Technology in E. coli

Bivalirudin as an anticoagulant for simultaneous integrated coronary artery revascularization – a novel approach to an inherent concern

(2011) Scott McClure et al.   CANADIAN JOURNAL OF CARDIOLOGY

SUMO Mediating Fusion Expression of Antimicrobial Peptide CM4 from two Joined Genes in Escherichia coli

(2010) Jian Feng Li et al.   CURRENT MICROBIOLOGY

Commentary: Bivalirudin Is a Safe and Effective Anticoagulant in the Percutaneous Treatment of Complex Infrainguinal Disease

(2010) Craig M. Walker   JOURNAL OF ENDOVASCULAR THERAPY

High-Level Expression and Purification of Heparin-Binding Epidermal Growth Factor (HB-EGF) with SUMO Fusion

(2009) Wuguang Lu et al.   MOLECULAR BIOTECHNOLOGY

Covalent conjugation of Groucho with SUMO-1 modulates its corepressor activity

(2008) Jang-Won Ahn et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Routine Use of the Direct Thrombin Inhibitor Bivalirudin for Off-Pump Coronary Artery Bypass Grafting is Safe and Effective

(2008) George J. Palmer et al.   HEART SURGERY FORUM